Over the last decade, advances in mobile technologies have enabled the development of intelligent systems that attempt to recognize and model a variety of health-related human behaviors. While automated dietary monitoring based on passive sensors has been an area of increasing research activity for many years, much less attention has been given to tracking fluid intake. In this work, we apply an adaptive segmentation technique on a continuous stream of inertial data captured with a practical, off-the-shelf wrist-mounted device to detect fluid intake gestures passively. We evaluated our approach in a study with 30 participants where 561 drinking instances were recorded. Using a leave-one-participant-out (LOPO), we were able to detect drinking episodes with 90.3% precision and 91.0% recall, demonstrating the generalizability of our approach. In addition to our proposed method, we also contribute an anonymized and labeled dataset of drinking and non-drinking gestures to encourage further work in the field.
Purpose of review: Ureteral stents are an invaluable tool for urologists but suffer from several drawbacks, including: limited durability due to stent encrustation, significant morbidity from bothersome urinary symptoms, pain and infection, risk of the forgotten stent and costly removal. This review highlights key advances in ureteral stent technology that seek to address these issues. Recent findings: Over the past 2 years clinical trials have brought ureteral stent technology aimed to reduce stent-associated morbidity closer to clinical application. Stent material and changes to stent design show promise in improving patient tolerability without increasing complications. Low-tech innovations such as magnetic and catheter snare removal may quickly reduce costs. Radical advances such as biodegradable stent materials remain in preclinical models but show promise for eliminating the need for stent removal. Summary: The ideal ureteral stent does not currently exist in clinical practice. This review highlights key studies that have advanced ureteral stent technology in the past 2 years.